Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
BAYER AG is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines, according to people with knowledge of the matter.
Leverkusen, Germany-based Bayer is working with Credit Suisse Group AG on the potential sale, three of...